Leonard D. Schaeffer Professorship in Health Care Policy
September 2026
Benefactor Report
Office of Alumni Affairs and Development
25 Shattuck Street
Boston, MA 02115
giving@hms.harvard.edu
Thank you from Dean Daley
September 8, 2026
Dear Leonard,
It’s always a pleasure to find a reason to write to you, and today, I am pleased to provide an update on the Leonard D. Schaeffer Professorship in Health Care Policy at Harvard Medical School and to share how your generosity continues to shape our work. Dr. Michael Chernew has had an exceptionally productive year, advancing rigorous research and policy leadership at a pivotal time for our health care system.
Michael’s scholarship continues to influence national debate on Medicare Advantage, alternative payment models, low-value care, and health care spending, with widely cited work in leading journals and policy outlets and ongoing advisory roles with the Centers for Medicare and Medicaid Services, the Congressional Budget Office, and the Massachusetts
Health Connector Board. Your support through the Schaeffer Professorship makes this possible by providing him with the resources and flexibility to pursue ambitious, data‑driven work that is guiding the future of Medicare and health care delivery.
Sincerely,
George Q. Daley, MD, PhD
George Q. Daley, MD, PhD | Dean of the Faculty of Medicine | Caroline Shields Walker Professor of Medicine
25 Shattuck Street, Boston, MA 02115 | t: (617) 432-1501 | e: George_Daley@hms.harvard.edu
Leonard, it was great to have you with us at the spring Board of Fellows meeting and to meet with you for lunch. Thank you for providing your perspective on the proposed Harvard Institute for Healthcare Transformation. I look forward to staying connected on this initiative and to seeing you soon for the Board of Fellows meeting and our visit. For now, thank you again for your enduring partnership and for all you do to advance thoughtful, impactful health policy.
Leonard D. Schaeffer Professorship
in Health Care Policy
Michael Chernew, PhD
Dr. Chernew is the Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab at Harvard Medical School. He studies novel benefit designs, Medicare Advantage, alternative payment models, low-value care, and health care spending trends. He chairs the Medicare Payment Advisory Commission and has contributed to technical advisory panels for the Centers for Medicare and Medicaid Services. He serves on the Congressional Budget Office’s Panel of Health Advisers and as vice chair of the Massachusetts Health Connector Board.
Ensuring a Sustainable Medicare Program Through Effective Oversight
In this study, the research team conducted a longitudinal analysis of Medicare Advantage oversight using more than a decade of civil monetary penalties and sanctions obtained via Freedom of Information Act requests. The study documented substantial temporal variation and generally modest penalty amounts, which raised questions about the deterrent effect of existing enforcement mechanisms. It further found that contracts serving higher proportions of low‑income and racially and ethnically minoritized beneficiaries were more likely to be subject to enforcement actions, which highlighted potential equity concerns in plan performance and regulatory response. Collectively, these results underscored the need for more systematic, data‑driven oversight to safeguard beneficiary protections, improve program integrity, and support the long‑term fiscal sustainability of Medicare.
The Opacity of Price Transparency
In this study, the research team used 2024 Transparency in Coverage data from five major US markets to examine how commercial insurers structure hospital payments. Analyzing contract-level payment methods for large national carriers, they classified inpatient and outpatient contracts by coding and pricing approach—such as fixed MS-DRG or HCPCS prices versus per diem rates, revenue codes, or percentages of charges. They found substantial variation across and within markets, with fixed-price methods governing only about half of contracts. This heterogeneity limited the comparability and practical usefulness of mandated price-transparency data for patients, purchasers, and researchers.
Year 1 Impact of Offering Non-Emergency Medical Transportation on Care Utilization Among Low-Income and Disabled Beneficiaries in Medicare Advantage
In this study, the research team evaluated the effects of adding a non-emergency medical transportation (NEMT) benefit following the 2019 expansion of “primarily health related” supplemental benefits. Using Massachusetts plan benefit, enrollment, and encounter data from 2016–2019 and an event-study framework, they compared changes in utilization for beneficiaries in plans that began offering NEMT versus similar plans that did not. The study found no statistically significant or economically meaningful changes in outpatient evaluation and management, procedure, imaging, or emergency department visits, and only small, statistically insignificant shifts in annual wellness visits and ambulance use days. These findings suggested that, in its first year, adding NEMT coverage did not measurably alter care utilization patterns in this population.
Research
Highlights
Dr. Chernew has had a remarkably productive year. He advanced his research agenda, publishing numerous peer‑reviewed studies and contributing a steady stream of policy commentary and thought pieces in leading outlets. Summaries and highlights are included below, with a full list of publications and writing projects at the end of the report.
He also received the prestigious William B. Graham Prize for Health Services Research in recognition of his contributions to improving the quality of, and access to, health care delivery worldwide. As he concludes his tenure as chair of the Medicare Payment Advisory Commission, an independent congressional agency that advises the U.S. Congress on issues affecting the Medicare program, Dr. Chernew remains one of the most active and influential voices in health policy.